Small Molecules

Insilico Medicine and MSK collaborate to discover new drug targets for gastroesophageal malignancies

by

Insilico Medicine (“Insilico”, 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and Memorial Sloan Kettering Cancer Center (MSK) have entered into a collaborative research agreement aimed at discovering new therapeutic targets for gastroesophageal malignancies. The initiative builds on MSK’s global leadership in this field under the direction of Yelena Y. Janjigian, MD, Carroll … Read more

Early biomarkers predict infections after breast reconstruction surgery

by

In the U.S., one in eight women will get breast cancer in their lifetime, and about half of them will have mastectomies. Many of those women opt to have their breasts surgically reconstructed, most commonly with implants, but a relatively high percentage develop infections after implant surgery, requiring intravenous antibiotics and often removal of the … Read more

Duke-NUS and NUS Medicine launch first-ever joint center to drive metabolomics research

by

In a strategic move for medical research and innovation, Duke-NUS Medical School and the National University of Singapore Yong Loo Lin School of Medicine (NUS Medicine) have launched the Systems Metabolomics center (SysMeC), their first-ever joint research center. This groundbreaking initiative is set to drive cutting-edge metabolomics research, unlocking new ways to detect diseases earlier … Read more

Insights from Thermo Fisher Scientific

by

Oral solid dose (OSD) drug formulations make up the majority of drugs on the market thanks to their patient-friendly administration and reliable storage stability. New technologies and formulation approaches are now being developed to enable a larger number of molecules to be delivered orally, including peptides, proteins, oligonucleotides, enzymes, and monoclonal antibodies. Contract Development and … Read more